Morgan Stanley Viatris Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Viatris Inc stock. As of the latest transaction made, Morgan Stanley holds 14,374,396 shares of VTRS stock, worth $129 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,374,396

Previous 14,761,483 2.62%

Holding current value

$129 Million

Previous $184 Million 31.88%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.68 - $12.42 $3.36 Million - $4.81 Million	-387,087 Reduced 2.62%	14,374,396 $125 Million
Q4 2024 Feb 14, 2025	BUY	$11.32 - $13.37 $2.06 Million - $2.44 Million	182,273 Added 1.25%	14,761,483 $184 Million
Q3 2024 May 14, 2025	SELL	$10.32 - $12.13 $26.2 Million - $30.8 Million	-2,539,324 Reduced 14.83%	14,579,210 $169 Million
Q3 2024 Nov 14, 2024	SELL	$10.32 - $12.13 $26.2 Million - $30.8 Million	-2,539,324 Reduced 14.83%	14,579,210 $169 Million
Q2 2024 May 14, 2025	BUY	$10.05 - $12.02 $23.7 Million - $28.3 Million	2,357,051 Added 15.97%	17,118,534 $182 Million
Q2 2024 Oct 17, 2024	BUY	$10.05 - $12.02 $27.8 Million - $33.2 Million	2,763,740 Added 19.25%	17,118,534 $182 Million
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $27.8 Million - $33.2 Million	2,763,740 Added 19.25%	17,118,534 $182 Million
Q1 2024 Oct 17, 2024	SELL	$11.27 - $13.53 $31.1 Million - $37.4 Million	-2,763,740 Reduced 16.14%	14,354,794 $171 Million
Q1 2024 Aug 16, 2024	BUY	$11.27 - $13.53 $12.6 Million - $15.2 Million	1,121,141 Added 8.47%	14,354,794 $171 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $12.6 Million - $15.2 Million	1,121,141 Added 8.47%	14,354,794 $171 Million
Q4 2023 Aug 16, 2024	SELL	$8.77 - $10.85 $34.1 Million - $42.2 Million	-3,884,881 Reduced 22.69%	13,233,653 $143 Million
Q4 2023 Feb 13, 2024	BUY	$8.77 - $10.85 $6.7 Million - $8.29 Million	764,292 Added 6.13%	13,233,653 $143 Million
Q3 2023 Nov 15, 2023	BUY	$9.59 - $11.35 $5.87 Million - $6.94 Million	611,774 Added 5.16%	12,469,361 $123 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $14.7 Million - $16.8 Million	1,633,350 Added 15.98%	11,857,587 $118 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $5 Million - $6.67 Million	-543,827 Reduced 5.05%	10,224,237 $98.4 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $4.56 Million - $6.04 Million	522,642 Added 5.1%	10,768,064 $120 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $3.28 Million - $4.31 Million	-386,994 Reduced 3.64%	10,245,422 $87.3 Million
Q2 2022 Oct 27, 2022	BUY	$9.95 - $12.27 $45 Million - $55.5 Million	4,522,533 Added 74.02%	10,632,416 $111 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $45 Million - $55.5 Million	4,522,533 Added 74.02%	10,632,416 $111 Million
Q1 2022 Oct 27, 2022	SELL	$9.81 - $15.4 $44.4 Million - $69.6 Million	-4,522,533 Reduced 42.54%	6,109,883 $66.5 Million
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $48.2 Million - $75.6 Million	-4,912,200 Reduced 44.57%	6,109,883 $66.5 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $68.9 Million - $83.6 Million	5,695,442 Added 106.92%	11,022,083 $149 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $70.6 Million - $80.6 Million	5,326,641 New	5,326,641 $72.2 Million

Others Institutions Holding VTRS

# of Institutions

1,127

Shares Held

943M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account